2007 Annual Meeting
Presentations from the ASENT 9th Annual Meeting:
Intellectual Property & Therapeutics Development
Fundamentals of Clinical Trials in Neurotherapeutics
Ion Channels as Targets for Neurotherapeutics Development
Disease Specific Clinical Trial Think Tanks
Neuroethics
Neurologic Therapeutics in Pediatrics
Sleep and Neurotherapeutics
To view a session, click 
to view
a PowerPoint slide presentation, 
to hear the audio,
and 
to view a video.
Thursday, March 8, 2007
Sixth Annual Advocacy Forum: Intellectual Property & Therapeutics Development
| Title |
Speaker(s) |
Duration |
Presentation |
Audio |
Video |
| Overview of Intellectual Property Law – What Are The Driving Forces for Today’s Drug Developers? |
Chief Judge Elect, The Honorable David Gersten;
Third District Court of Appeals, Miami, FL |
|
|
|
|
| NIH and the Role of Federal Funding in the Generation of Intellectual Property |
Mark Rohrbaugh,PhD, Director NIH Office of Technology Transfer; Rockville, MD |
|
|
|
|
| Academic Institutions as Generators, Holders and Transferors of IP |
Michael Cleare, PhD, Executive Director, Science and Technology Ventures, Columbia University New York, NY |
|
|
|
|
| Accelerating Therapeutics Development – A New Vision |
Blumenstein, President, MRSSI and Senior Advisor to the High Q Foundation, New York, NY |
|
|
|
|
Fundamentals of Clinical Trials in Neurotherapeutics
| Title |
Speaker(s) |
Duration |
Presentation |
Audio |
Video |
| Introduction: Stages of Therapeutic Development |
Roger J. Porter, M.D. |
|
|
|
|
| Nonclinical Studies |
Eric Siemers, M.D., Eli Lilly & Company |
|
|
|
|
| Trial Design – Early Development |
Karl Kieburtz, M.D., Professor of Neurology, University of Rochester |
|
|
|
|
| Trial Design – Late Development |
John Marler, M.D., NIH |
|
|
|
|
| Alternative Trial Designs |
Michael Krams, M.D., Wyeth |
|
|
|
|
| Clinical Trial Statistics |
Barbara Tilley, Ph.D., Medical University of South Carolina |
|
|
|
|
| Ethics of Clinical Trials |
Ira Shoulson, M.D., Professor, University of Rochester |
|
|
|
|
| The Clinical Trial Team |
Lucinda Wilson, Prestwick Pharmaceuticals, Kenneth W. Sommerville M.D., Vice President of Medical Therapeutics, Schwarz Biosciences |
|
|
|
|
Friday, March 9, 2007
Symposium: Ion Channels as Targets for Neurotherapeutics Development
| Title |
Speaker(s) |
Duration |
Presentation |
Audio |
Video |
| Profiling Human Ion Channel Gene Variation |
Jeffrey Noebels, M.D., Ph.D., Baylor College of Medicine |
|
|
|
|
| Sodium and Calcium Channels |
William Catterall, Ph.D., University of Washington |
|
|
|
|
| KCNQ Potassium Channels: Drug Targets for the Treatment of Epilepsy and Pain |
Gregory C. Rigdon, Ph.D., Icagen, Inc. |
|
|
|
|
| Nicotinic Receptors in Nicotine Addiction and Parkinson's Disease |
Henry Lester, Ph.D., California Institute of Technology |
|
|
|
|
| Targeting Voltage-gated Calcium Channels in Central and Peripheral Nociceptive Pathways |
Terrance P. Snutch, PhD, FRSC, University of British Columbia & Neuromed Pharmaceuticals Inc |
|
|
|
|
Workshop: Disease Specific Clinical Trial Think Tanks
| Title |
Speaker(s) |
Duration |
Presentation |
Audio |
Video |
| Stroke |
Marc Fisher, M.D. (STAIR) |
|
|
|
|
| Epilepsy |
Jackie French, M.D. (AED IX) |
|
|
|
|
| Pain |
John Farrar, M.D., Ph.D. (IMMPACT) |
|
|
|
|
| Psychiatry |
Michael F. Green, PhD, (MATRICS) |
|
|
|
|
| FDA Collaboration with Neurologic Specialties Through Interactive Clinical Trial Meetings |
Robert Rappaport, M.D., Center for Drug Evaluation and Research, FDA |
|
|
|
|
Workshop: Neuroethics
| Title |
Speaker(s) |
Duration |
Presentation |
Audio |
Video |
| Ethics 2007 - The Honorable David Gersten, Third District Court of Appeals, Miami, FL - A Brief History of Conflict of Interest in Research |
Roger J. Porter, M.D. |
|
|
|
|
| Justifying the Risks of Research |
Jason Karlawish, M.D., University of Pennsylvania |
|
|
|
|
| Ethics of Surrogate Consent for Research |
Jason Karlawish, M.D., University of Pennsylvania |
|
|
|
|
Dinner Symposium: Neurologic Therapeutics in Pediatrics
| Title |
Speaker(s) |
Duration |
Presentation |
Audio |
Video |
| The State of Clinical Pediatric Trials in the United States |
Edward Kaye, M.D., Vice President of Clinical Research, Genzyme Corporation |
|
|
|
|
| The State of Clinical Pediatric Trials in Europe |
Virinder Nohria,M.D., Ph.D. |
|
|
|
|
| The NIH Contribution to Clinical Trials in the US |
Anne Zajicek, M.D., Senior Program Officer, NICHD, NIH |
|
|
|
|
| The Pediatric Rule--How It Succeeds and How It Fails |
Russell Katz, M.D., Director of Neuropharmacology, FDA |
|
|
|
|
Saturday, March 10, 2007
Symposium: Sleep and Neurotherapeutics
| Title |
Speaker(s) |
Duration |
Presentation |
Audio |
Video |
| Basic Mechanisms of Sleep |
Clifford Saper, M.D., Ph.D., Beth Israel Hospital |
|
|
|
|
| Epilepsy and Sleep |
Beth Malow, M.D., M.S., Vanderbilt University |
|
|
|
|
| Parkinson's Disease and Sleep |
David Rye, M.D., Ph.D., Emory University Hospital |
|
|
|
|
| Treatments for Sleep Disorders: Regulatory Challenges and Standards of Evidence |
Russell Katz, M.D., Director of Neuropharmacology, FDA |
|
|
|
|
